BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1989 related articles for article (PubMed ID: 14557527)

  • 1. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine prescription practices and substance abuse in persons with severe mental illness.
    Clark RE; Xie H; Brunette MF
    J Clin Psychiatry; 2004 Feb; 65(2):151-5. PubMed ID: 15003066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term course of substance use disorders among patients with severe mental illness.
    Bartels SJ; Drake RE; Wallach MA
    Psychiatr Serv; 1995 Mar; 46(3):248-51. PubMed ID: 7796211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent validity of clinicians' ratings of substance abuse among psychiatric outpatients.
    Carey KB; Cocco KM; Simons JS
    Psychiatr Serv; 1996 Aug; 47(8):842-7. PubMed ID: 8837156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.
    Horsfall J; Cleary M; Hunt GE; Walter G
    Harv Rev Psychiatry; 2009; 17(1):24-34. PubMed ID: 19205964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: changes in psychiatric symptoms and substance use.
    Margolese HC; Carlos Negrete J; Tempier R; Gill K
    Schizophr Res; 2006 Mar; 83(1):65-75. PubMed ID: 16460917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differing effects of antipsychotic medications on substance abuse treatment patients with co-occurring psychotic and substance abuse disorders.
    Stuyt EB; Sajbel TA; Allen MH
    Am J Addict; 2006; 15(2):166-73. PubMed ID: 16595355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzodiazepine prescription among patients with severe mental illness and co-occurring alcohol abuse/dependence in Taiwan.
    Lin SC; Chen CC; Chen YH; Chung KS; Lin CH
    Hum Psychopharmacol; 2011 Apr; 26(3):201-7. PubMed ID: 21671270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intricate link between violence and mental disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Elbogen EB; Johnson SC
    Arch Gen Psychiatry; 2009 Feb; 66(2):152-61. PubMed ID: 19188537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Description of medicosocial profiles of pharmacodependent subjects consulting addictology centres using a computerized database].
    Landreat MG; Vigneau CV; Bronnec MG; Sebille-Rivain V; Venisse JL; Jolliet P
    Encephale; 2011 Dec; 37(6):418-24. PubMed ID: 22137213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders.
    San L; Arranz B; Martinez-Raga J
    Eur Addict Res; 2007; 13(4):230-43. PubMed ID: 17851245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-year recovery outcomes for long-term patients with co-occurring schizophrenic and substance use disorders.
    Xie H; McHugo GJ; Helmstetter BS; Drake RE
    Schizophr Res; 2005 Jun; 75(2-3):337-48. PubMed ID: 15885525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of patients with substance abuse diagnoses on a general psychiatry unit in a VA Medical Center.
    Lambert MT; Griffith JM; Hendrickse W
    Psychiatr Serv; 1996 Oct; 47(10):1104-7. PubMed ID: 8890339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of benzodiazepine use on methadone maintenance treatment outcomes.
    Brands B; Blake J; Marsh DC; Sproule B; Jeyapalan R; Li S
    J Addict Dis; 2008; 27(3):37-48. PubMed ID: 18956528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis.
    Rubio G; Marín-Lozano J; Ferre F; Martínez-Gras I; Rodriguez-Jimenez R; Sanz J; Jimenez-Arriero MA; Carrasco JL; Lora D; Jurado R; López-Trabada JR; Palomo T
    Compr Psychiatry; 2012 Nov; 53(8):1063-70. PubMed ID: 22682680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of receipt of a psychiatric diagnosis for completion of college.
    Hunt J; Eisenberg D; Kilbourne AM
    Psychiatr Serv; 2010 Apr; 61(4):399-404. PubMed ID: 20360280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Working memory and depressive symptoms in patients with schizophrenia and substance use disorders.
    Potvin S; Pampoulova T; Lipp O; Ait Bentaleb L; Lalonde P; Stip E
    Cogn Neuropsychiatry; 2008 Jul; 13(4):357-66. PubMed ID: 18622790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State psychiatric hospital patients with past arrests for violent crimes.
    Grossman LS; Haywood TW; Cavanaugh JL; Davis JM; Lewis DA
    Psychiatr Serv; 1995 Aug; 46(8):790-5. PubMed ID: 7583479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 100.